EQS-News: Drägerwerk AG & Co. KGaA: Dräger with good demand in the first nine months of 2024
EQS-News: Drägerwerk AG & Co. KGaA
/ Key word(s): Preliminary Results/Forecast
Dräger with good demand in the first nine months of 2024
Lübeck – Dräger's preliminary order intake rose by 1.4 percent (net of currency effects; nominal: 0.7 percent) to around EUR 2,421 million in the first nine months of 2024 and was therefore higher than the prior year's high level (9 months 2023: EUR 2,403.3 million). In the safety division, order intake rose by 6.5 percent (net of currency effects; nominal: 6.0 percent) to around EUR 1,052 million (9 months 2023: EUR 992.7 million). In the medical division, it decreased by 2.1 percent (net of currency effects; nominal: -3.0 percent) to around EUR 1,368 million (9 months 2023: EUR 1,410.7 million). This was due in particular to the significant decline in demand for ventilators, which had still been supported by China in the first quarter of 2023. At around EUR 2,295 million, net sales were 0.4 percent (net of currency effects; nominal: -1.1 percent) below the prior-year figure (9 months 2023: EUR 2,320.9 million). In the prior-year period, Dräger had benefited from strong catch-up effects as a result of the noticeable improvement in delivery capacity and the surge in demand for ventilators in China. As expected, both effects were absent in the first nine months of 2024. The safety division continued its net sales growth in the first nine months of 2024 and recorded an increase of 5.5 percent (net of currency effects; nominal: 5.0 percent) to around EUR 1,010 million (9 months 2023: EUR 961.7 million). The medical division recorded a decline of 4.6 percent (net of currency effects; nominal: -5.4 percent) to around EUR 1,285 million (9 months 2023: EUR 1,359.2 million), which is attributable in particular to the aforementioned base effects in the prior year. The Group's gross margin rose to around 44.4 percent (9 months 2023: 44.0 percent). Earnings before interest and taxes (EBIT) increased by around four percent to around EUR 80 million (9 months 2023: EUR 76.9 million). In addition to the operating business performance, several one-time effects with an impact on earnings contributed around EUR 30 million to EBIT in the course of the first nine months. Business performance in the third quarter of 2024 At around EUR 775 million, net sales were 0.7 percent below (net of currency effects; nominal: -1.8 percent) the prior-year figure (Q3 2023: EUR 788.5 million). The safety division recorded a decrease of 0.6 percent (net of currency effects; nominal: -1.3 percent) to around EUR 336 million (Q3 2023: EUR 340.1 million). The medical division recorded a decline of 0.8 percent (net of currency effects; nominal: -2.1 percent) to around EUR 439 million (Q3 2023: EUR 448.4 million). This is due in particular to the weak development in China. The Group's gross margin stood at around 43.5 percent (Q3 2023: 44.0 percent). EBIT amounted to around EUR 24 million (Q3 2023: EUR 29.2 million). This included a one-time effect of around EUR 10 million from a sale of a building. The EBIT margin amounted to around 3.1 percent (Q3 2023: 3.7 percent). Dräger confirms its outlook for the current fiscal year and expects net sales to increase by 1.0 to 5.0 percent (net of currency effects) and an EBIT margin of 2.5 to 5.5 percent. We continue to expect net sales growth in the lower half and an EBIT margin in the upper half of the forecast range. The full results for the first nine months of the fiscal year will be published on October 29, 2024. Disclaimer
16.10.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | Drägerwerk AG & Co. KGaA |
Moislinger Allee 53-55 | |
23558 Lübeck | |
Germany | |
Phone: | +49 (0)451 882-0 |
Fax: | +49 (0)451 882-2080 |
E-mail: | info@draeger.com |
Internet: | www.draeger.com |
ISIN: | DE0005550602, DE0005550636 (Vorzugsaktien) |
WKN: | 555060, 555063 (Vorzugsaktien) |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Stuttgart, Tradegate Exchange |
EQS News ID: | 2009063 |
End of News | EQS News Service |
|
2009063 16.10.2024 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
The most important financial data at a glance | ||||||||
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | ||
Sales1 | 2.595,01 | 2.780,82 | 3.406,78 | 3.328,42 | 3.045,23 | 3.375,50 | 3.425,00 | |
EBITDA1,2 | 147,91 | 193,71 | 521,07 | 421,00 | 55,80 | 315,00 | 304,00 | |
EBITDA-Margin3 | 5,70 | 6,97 | 15,30 | 12,65 | 1,83 | 9,33 | 8,88 | |
EBIT1,4 | 62,65 | 66,58 | 396,60 | 271,68 | -88,61 | 166,43 | 171,00 | |
EBIT-Margin5 | 2,41 | 2,39 | 11,64 | 8,16 | -2,91 | 4,93 | 4,99 | |
Net Profit (Loss)1 | 34,90 | 33,79 | 249,89 | 154,27 | -63,64 | 111,99 | 104,00 | |
Net-Margin6 | 1,35 | 1,22 | 7,34 | 4,64 | -2,09 | 3,32 | 3,04 | |
Cashflow1,7 | 4,09 | 164,42 | 459,98 | 384,89 | -144,23 | 189,68 | 0,00 | |
Earnings per share8 | 1,42 | 1,38 | 10,19 | 7,13 | -3,41 | 5,86 | 5,40 | |
Dividend per share8 | 0,13 | 0,13 | 0,13 | 0,13 | 0,13 | 1,74 | 1,54 |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: -
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
INVESTOR-INFORMATION | ||||||
©boersengefluester.de | ||||||
Drägerwerk ST | ||||||
WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
555060 | DE0005550602 | AG & Co. KGaA | 806,96 Mio € | 21.06.2010 | Kaufen | 9F5GVM4C+V2 |
PE 2025e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
7,20 | 17,03 | 0,42 | 11,08 | 0,56 | 4,03 | 0,24 |
Dividend '2022 in € |
Dividend '2023 in € |
Dividend '2024e in € |
Div.-Yield '2024e in % |
0,13 | 1,74 | 1,54 | 3,78% |
Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
09.05.2025 | 30.04.2025 | 25.07.2024 | 29.10.2024 | 03.04.2025 |
Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
-3,73% | -7,52% | -8,95% | -7,92% | +0,00% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.